EF Hutton Reiterates Buy on UMH Properties, Maintains $21 Price Target
EF Hutton analyst Gaurav Mehta reiterates UMH Properties (NYSE:UMH) with a Buy and maintains $21 price target.
Needham Reiterates Buy on Applied Mat, Maintains $135 Price Target
Needham analyst Quinn Bolton reiterates Applied Mat (NASDAQ:AMAT) with a Buy and maintains $135 price target.
Needham Reiterates Buy on Nerdy, Maintains $5 Price Target
Needham analyst Ryan MacDonald reiterates Nerdy (NYSE:NRDY) with a Buy and maintains $5 price target.
Needham Reiterates Buy on Avidity Biosciences, Maintains $35 Price Target
Needham analyst Joseph Stringer reiterates Avidity Biosciences (NASDAQ:RNA) with a Buy and maintains $35 price target.
Needham Reiterates Buy on Shutterstock, Maintains $90 Price Target
Needham analyst Bernie McTernan reiterates Shutterstock (NYSE:SSTK) with a Buy and maintains $90 price target.
Needham Reiterates Buy on Duolingo, Maintains $115 Price Target
Needham analyst Ryan MacDonald reiterates Duolingo (NASDAQ:DUOL) with a Buy and maintains $115 price target.
HC Wainwright & Co. Reiterates Buy on Celldex Therapeutics, Maintains $73 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Celldex Therapeutics (NASDAQ:CLDX) with a Buy and maintains $73 price target.
HC Wainwright & Co. Reiterates Buy on Bicycle Therapeutics, Maintains $57 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintains $57 price target.
HC Wainwright & Co. Reiterates Buy on Iovance Biotherapeutics, Maintains $38 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Iovance Biotherapeutics (NASDAQ:IOVA) with a Buy and maintains $38 price target.
HC Wainwright & Co. Reiterates Buy on Syndax Pharmaceuticals, Maintains $33 Price Target
HC Wainwright & Co. analyst Edward White reiterates Syndax Pharmaceuticals (NASDAQ:SNDX) with a Buy and maintains $33 price target.